España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
C4 Therapeutics
CCCC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.95
0.10
2.73%
At close: -
$3.97
0.02
0.51%
After Hours: 7:31 PM EDT
Get Report
Comment
C4 Therapeutics (CCCC) Forecast
News
Earnings
C4 Therapeutics (CCCC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for C4 Therapeutics (NASDAQ:CCCC) Stock
C4 Therapeutics Stock (NASDAQ: CCCC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 19, 2024
AT&T To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
Wells Fargo Upgrades C4 Therapeutics to Overw...
Benzinga Newsdesk
Sunday, December 08, 2024
C4 Therapeutics Presented Cemsidomide Phase 1...
Benzinga Newsdesk
Monday, November 18, 2024
Stephens & Co. Initiates Coverage On C4 Thera...
Benzinga Newsdesk
Wednesday, November 06, 2024
C4 Therapeutics Announced Its Partner Betta P...
Benzinga Newsdesk
Tuesday, November 05, 2024
C4 Therapeutics To Present Phase 1/2 Trial Da...
Benzinga Newsdesk
Friday, September 13, 2024
C4 Therapeutics Presents Monotherapy Data Dem...
Benzinga Newsdesk
Tuesday, September 10, 2024
C4 Therapeutics shares are trading higher aft...
Benzinga Newsdesk
C4 Therapeutics Has Delivered A Second Develo...
Benzinga Newsdesk
Monday, September 09, 2024
Methanex, Merck And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
C4 Therapeutics shares are trading lower. The...
Benzinga Newsdesk
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Reported Sunday, C4 Therapeutics To Reveal Pr...
Benzinga Newsdesk
Wednesday, August 14, 2024
C4 Therapeutics Announced The ESMO Congress D...
Benzinga Newsdesk
Tuesday, August 06, 2024
BMO Capital Reiterates Outperform on C4 Thera...
Benzinga Newsdesk
Thursday, August 01, 2024
C4 Therapeutics Q2 2024 GAAP EPS $(0.26) Beat...
Benzinga Newsdesk
Tuesday, July 16, 2024
C4 Therapeutics To Present Preliminary Monoth...
Benzinga Newsdesk
Monday, June 10, 2024
C4 Therapeutics Taps Ron Cooper of Albireo Ph...
Benzinga Newsdesk
Thursday, May 09, 2024
Key Takeaways From C4 Therapeutics Analyst Ratings
Benzinga Insights
Wells Fargo Maintains Equal-Weight on C4 Ther...
Benzinga Newsdesk
Stifel Maintains Buy on C4 Therapeutics, Rais...
Benzinga Newsdesk
Wednesday, May 08, 2024
C4 Therapeutics' Cash, Cash Equivalents and M...
Benzinga Newsdesk
C4 Therapeutics Q1 2024 GAAP EPS $(0.41) Beat...
Benzinga Newsdesk
Monday, April 08, 2024
C4 Therapeutics Presents New Preclinical Data...
Benzinga Newsdesk
Tuesday, March 05, 2024
C4 Therapeutics To Present New Preclinical Da...
Benzinga Newsdesk
Monday, March 04, 2024
C4 Therapeutics shares are trading higher aft...
Benzinga Newsdesk
C4 Therapeutics Has Entered Into A License Ag...
Benzinga Newsdesk
Monday, February 26, 2024
Breaking Down C4 Therapeutics: 4 Analysts Share Their Views
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on C4 T...
Benzinga Newsdesk
Thursday, February 22, 2024
C4 Therapeutics' Cash, Cash Equivalents And M...
Benzinga Newsdesk
C4 Therapeutics FY EPS $(2.67) Down From $(2....
Benzinga Newsdesk
Tuesday, February 20, 2024
Capital One Financial To Acquire Discover, Joins SSR Mining And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Monday, January 29, 2024
Analyst Expectations For C4 Therapeutics's Future
Benzinga Insights
JP Morgan Upgrades C4 Therapeutics to Neutral...
Benzinga Newsdesk
Tuesday, January 09, 2024
C4 Therapeutics Announces 2024 Priorities; Un...
Benzinga Newsdesk
Tuesday, December 26, 2023
RA Capital Management Reports 9.9% Passive St...
Benzinga Newsdesk
Friday, December 22, 2023
C4 Therapeutics 13G Filing Shows Commodore Ca...
Benzinga Newsdesk
Friday, December 15, 2023
What's Going On With C4 Therapeutics Stock?
Erica Kollmann
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Chris Katje
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Wednesday, December 13, 2023
Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady
Avi Kapoor
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet
Avi Kapoor
US Stocks Mixed; Producer Prices Unchanged For November
Avi Kapoor
C4 Therapeutics Stock Is Surging Wednesday: What's Going On?
Adam Eckert
C4 Therapeutics shares are trading higher aft...
Benzinga Newsdesk
Market-Moving News for December 13th
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch